Funding · Company
Jnana Therapeutics Inc.
Boston, MABiotech & Pharma
Jnana Therapeutics Inc. of Boston, MA has disclosed $157M across 2 Form D offerings filed with the SEC between Aug 24, 2021 and Jan 26, 2024.
$157M
Total disclosed
2
Form D offerings
2016
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$107M
Form D · Jan 26, 2024 ↗
Q1 2024
· 1 amendment, first filed Nov 16, 2022
Filing details
HeadquartersBoston, MAIndustryBiotech & Pharma (Biotechnology)Incorporated2016SEC CIK0001879148Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →